The research, funded by a €2.4 million grant via the European Research Council, will track 10,000 people aged 50 to 75 divided into two groups: moderate drinkers and abstainers.
Patients with type 2 diabetes treated with automated insulin delivery significantly reduced glucose levels compared to those receiving usual care, highlighting the AID system's effectiveness.
The recent clinical trial published in JAMA Oncology revealed that a combination treatment of a PARP inhibitor and chemotherapy did not improve survival in glioblastoma patients compared to placebo.